Jun Liu1 , Chengyi Song2, Zhuoping Liang1, Xiang Long2, Min Guo2, Jianle Xu1
1Department of Otolaryngology, Head and Neck Surgery; 2Department of Anesthesiology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China.For correspondence:- Jun Liu Email: liujunluzhou@163.com Tel:+868303165641
Accepted: 18 June 2021 Published: 29 July 2021
Citation: Liu J, Song C, Liang Z, Long X, Guo M, Xu J. Licoflavanone exerts anticancer effects on human nasopharyngeal cancer cells via caspase activation, suppression of cell migration and invasion, and inhibition of m-TOR/PI3K/AKT pathway. Trop J Pharm Res 2021; 20(7):1387-1393 doi: 10.4314/tjpr.v20i7.10
© 2021 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Archives
News Updates